Small cap wrap: Purepoint Uranium, Custom Health, Standard Uranium, Blockmate

Purepoint Uranium approved a 2027 exploration plan for its Dorado project. Custom Health reported 220% revenue growth to US$14.4M. Standard Uranium confirmed geology at its Rocas project. Blockmate Ventures ordered its first NVIDIA B200 compute node. 374Water saw 83% revenue increase. Allergy Therapeutics plans to delist from AIM. Pantheon Resources raised £7.5M. IXICO developed an AI tool for Alzheimer's drug safety checks.

Original reporting
Published Nov 17, 2026, 8:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 10:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$SCWO
Bullish
high confidence
Mentioned
$SCWO
Relevance
7/10
AlphAI data visualization · based on proactiveinvestors.com
Decision brief

The 30-second read

$SCWOBullishMed
01

Why it matters

The most tradable signals are the quantified Q3 revenue/gross profit jump for Custom Health, the quantified revenue and cash-burn improvement for 374Water, and the broker forecast/target lift for Ceres Power. Several other names have catalysts that are concrete but still execution-dependent (drilling, hardware installation, AI tool development).

02

Market read

Traders can use the quantified operating updates and broker forecast changes for near-term positioning, while treating drilling and product/hardware milestones as medium-term optionality.

03

What to watch

For the AIM delisting and the equity raise, liquidity and dilution mechanics can dominate fundamentals; traders should watch trading halt/stop dates and share issuance details.

Relevance 7/10Novelty 5/10Timing: today’s small-cap catalysts and broker actions, with several events tied to 2026-27 timelines

Background

This is a multi-name small-cap wrap covering exploration approvals, quarterly results, broker target changes, capital raises, listing changes, and product/technology updates.

Company-level read

Ticker impact

$SCWOBullishHigh confidence
Context

374Water reported nine-month revenue up 83% to US$3.47 million and a sharp reduction in cash used in operations as AirSCWO deployments advance.

Expected impact

Likely positive reaction as investors re-rate the company on accelerating commercial traction and better operating cash efficiency.

Evidence & confidence

The article provides multiple quantified operating metrics (revenue, gross profit, gross margin, and cash used reduction) tied to commercial deployment progress.

Market effects

Uranium exploration updates and AI/healthcare commercialization signals reinforce risk-on interest in small-cap resource and healthcare tech names.

Primarily UK/Canada-listed small caps, with potential spillover into broader AIM and TSX-V sentiment.

Limited direct macro linkage; indirect relevance through AI compute supply chain and healthcare imaging innovation narratives.

Counterpoint

Several items are early-stage (exploration plans, first hardware node, AI tool development) and may not translate into near-term revenue, so price moves could fade quickly.

Key entities

  • Purepoint Uranium Group Inc

    Dorado project JV approved a 2027 exploration plan with 14 diamond drill holes totaling 7,700 metres.

  • Custom Health Holdings Inc

    Q3 revenue rose 220% to US$14.4 million on first full quarter contribution from InnovativeRx.

  • Ceres Power Holdings PLC

    UBS raised its target to 1,000p and increased 2027 earnings forecasts by 10% after a new European manufacturing agreement.

  • Standard Uranium Ltd

    Rocas project drilling confirmed basement-hosted uranium system geology and reported rare earth grades up to 0.99%.

  • Blockmate Ventures Inc

    Ordered its first NVIDIA B200 compute node and selected a US data centre for Q1 2027 installation.

Related articles

$SCWOMed

374Water Reports Second Quarter 2026 Financial Results; Revenue Increases More Than 280% Year-Over-Year

374Water Inc. (SCWO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 374Water Reports Second Quarter 2026 Financial Results; Revenue Increases More Than 280% Year-Over-Year Quarterly revenue exceeds $2.2 million as the Company begins translating commercial milestones into financial results MORRISVILLE, NC – August 18, 2026 / ACCESS Ne

$SCWOMed

374Water Flat on Q2 Numbers

374Water Inc. (NASDAQ:SCWO) reported Q2 ended June 30, 2026 revenue of $2.26M versus about $0.6M in Q2 2025, up about 280%, driven by completion of Orange County Sanitation District Factory Acceptance Test. Q2 gross profit was $1.98M (87% margin). Company said milestone enables recognition of about $2.0M and invoicing remaining $2.6M of the OC San contract.